# Development of Endothelial Biomarkers

> **NCT02006810** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 50 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **BEHAVIORAL:** Induction of endothelial function variations

## Key facts

- **NCT ID:** NCT02006810
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-12-19
- **Final completion:** 2017-09-19
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006810, "Development of Endothelial Biomarkers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02006810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*